Silo Pharma, Inc. (NASDAQ:SILO) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of common stock (or pre-funded warrants) with Series A-3 and Series A-4 warrants Announced: about US$4M · US$6.452 a share · Warrants at US$6.21 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Jul 10, 2026 |
| Registered direct offering of shares of common stock with concurrent unregistered warrants Closed: US$2.5M raised · US$0.875 a share · Warrants at US$0.75 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Oct 1, 2025 |
| Public offering of shares of common stock (or pre-funded warrants) with series A-1 and A-2 warrants Closed: US$2M raised · US$0.6 a share · Warrants at US$0.6 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: General working capital purposes | May 16, 2025 |